Maybridge is a leading producer of high-quality innovative organic compounds for drug discovery and development in the pharmaceutical, biotechnology and agrochemical industries.
These compounds are particularly suitable for
As a result of the developments in genomic research the number of new protein/receptor targets is set to increase dramatically. Screening continues to be a very important tool for drug discovery, particularly for general screening of structurally uncharacterised targets. Against such targets discovery efficiency and productivity can obviously be improved by screening libraries designed to offer maximum diversity whilst retaining drug-like characteristics. The Maybridge Screening library offers just that - molecules from every galaxy within the chemical universe.
The drug discovery process is long and expensive. Our aim is to help you to shorten this process, by producing a diverse collection of drug-like molecules, which provide value in Screening programmes.
For more information, refer to the Screening Guide below.